Monitoring effects of oral anticoagulants during treatment with heparin.
作者信息
Thomas P, Fennerty A, Backhouse G, Bentley D P, Campbell I A, Routledge P A
出版信息
Br Med J (Clin Res Ed). 1984 Jan 21;288(6412):191. doi: 10.1136/bmj.288.6412.191.
Abstract
摘要
相似文献
1
Monitoring effects of oral anticoagulants during treatment with heparin.在肝素治疗期间监测口服抗凝剂的效果。
Br Med J (Clin Res Ed). 1984 Jan 21;288(6412):191. doi: 10.1136/bmj.288.6412.191.
2
[Heparin and monitoring of peroral anticoagulant therapy].[肝素与口服抗凝治疗的监测]
Ugeskr Laeger. 1986 May 19;148(21):1275-6.
3
Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.肝素联合使用对心房颤动导管消融术中华法林疗效的影响。
Heart Vessels. 2016 Mar;31(3):397-401. doi: 10.1007/s00380-014-0608-2. Epub 2014 Dec 4.
4
Letter: Decreased sensitivity to oral anticoagulant therapy after attacks of migraine.信函：偏头痛发作后口服抗凝治疗敏感性降低
Lancet. 1974 Nov 9;2(7889):1143. doi: 10.1016/s0140-6736(74)90905-2.
5
Comparison of heparin and streptokinase in the treatment of venous thrombosis.肝素与链激酶治疗静脉血栓形成的比较。
Am Surg. 1975 Sep;41(9):511-19.
6
[Treatment of pulmonary embolism. I. Treatment with heparin and oral anticoagulants].[肺栓塞的治疗。I. 肝素及口服抗凝剂治疗]
Pneumonol Pol. 1984 Sep;52(9):447-52.
7
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
N Engl J Med. 1979 Oct 18;301(16):855-8. doi: 10.1056/NEJM197910183011602.
8
Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.预防性抗凝治疗预防心肌梗死后小腿静脉血栓形成
N Engl J Med. 1973 Apr 19;288(16):815-7. doi: 10.1056/NEJM197304192881604.
9
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.磁共振静脉造影评估依度沙班单药治疗与胃肠外抗凝/华法林治疗对有症状的深静脉血栓形成患者血栓溶解情况的对比：一项多中心可行性研究。
Vasc Med. 2016 Aug;21(4):361-8. doi: 10.1177/1358863X16645853. Epub 2016 May 10.
10
Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?静脉血栓栓塞的长期预防：低分子肝素还是口服抗凝药？
Haemostasis. 1998;28 Suppl 3:17-21. doi: 10.1159/000022401.
引用本文的文献
1
Anticoagulation after intracoronary stent insertion.冠状动脉支架置入术后的抗凝治疗。
Br Heart J. 1994 Sep;72(3):294-6. doi: 10.1136/hrt.72.3.294.
2
Flexible induction dose regimen for warfarin and prediction of maintenance dose.华法林的灵活诱导剂量方案及维持剂量预测
Br Med J (Clin Res Ed). 1984 Apr 28;288(6426):1268-70. doi: 10.1136/bmj.288.6426.1268.
3
Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.华法林的临床药代动力学与药效学。理解剂量效应关系。
Clin Pharmacokinet. 1986 Nov-Dec;11(6):483-504. doi: 10.2165/00003088-198611060-00005.
4
Anticoagulants in venous thromboembolism.静脉血栓栓塞中的抗凝剂。
BMJ. 1988 Nov 19;297(6659):1285-8. doi: 10.1136/bmj.297.6659.1285.
5
The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing.1987年史克必成讲座。临床药理学与定制处方的艺术。
Br J Clin Pharmacol. 1988 Oct;26(4):339-45. doi: 10.1111/j.1365-2125.1988.tb03390.x.
6
Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy.口服抗凝治疗控制中的临床药代动力学考量
Clin Pharmacokinet. 1989 Apr;16(4):238-53. doi: 10.2165/00003088-198916040-00003.
7
Control of warfarin therapy.华法林治疗的控制
Postgrad Med J. 1990 Feb;66(772):155. doi: 10.1136/pgmj.66.772.155.
本文引用的文献
1
A rapid procedure for laboratory control of simultaneous treatment with intravenous heparin and oral anticoagulant.一种用于实验室监测静脉注射肝素与口服抗凝剂联合治疗的快速方法。
Acta Med Scand. 1972 Jul-Aug;192(1-2):125-8. doi: 10.1111/j.0954-6820.1972.tb04788.x.
2
Factors affecting warfarin requirements. A prospective population study.影响华法林需求量的因素。一项前瞻性人群研究。
Eur J Clin Pharmacol. 1979 Jun 12;15(5):319-22. doi: 10.1007/BF00558434.
3
Predicting patients' warfarin requirements.预测患者对华法林的需求量。
Lancet. 1977 Oct 22;2(8043):854-5. doi: 10.1016/s0140-6736(77)90786-3.
Zotero 插件